LH
NVO

Lebenthal Holdings’s Novo Nordisk NVO Stock Holding History

Lebenthal Holdings’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-24,910
Closed -$675K – 379
2016
Q1 		$675K Sell
24,910
-8,606
-26% -$231K 0.12% 222
2015
Q4 		$974K Sell
33,516
-43,228
-56% -$1.2M 0.23% 150
2015
Q3 		$2.08M Buy
76,744
+7,072
+10% +$200K 0.48% 76
2015
Q2 		$1.91M Sell
69,672
-21,944
-24% -$617K 0.39% 109
2015
Q1 		$2.45M Buy
+91,616
New +$2.11M 0.58% 57

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Lebenthal Holdings's NVO Position: Q2 2016 in Review

Lebenthal Holdings sold out of Novo Nordisk (NVO) in Q2 2016, closing a stake of 24,910 shares — an estimated $675K sold.

Lebenthal Holdings first reported a position in NVO in Q1 2015 and held it in 5 quarters. The position peaked at $2.45M in Q1 2015. 530 funds tracked by Wall St. Rank hold NVO as of Q2 2016.

  • Lebenthal Holdings reported no remaining Novo Nordisk position as of Q2 2016 after selling out during the quarter.
  • Lebenthal Holdings sold 24,910 Novo Nordisk shares in Q2 2016, an estimated $675K.
  • Lebenthal Holdings first reported a position in Novo Nordisk in Q1 2015 and held it in 5 quarters.
  • Lebenthal Holdings's Novo Nordisk position peaked at $2.45M in Q1 2015.
  • 530 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.